news > company

news > industry

news > products

Molybdenum ( Mo-100)

Lizeth ⎜Apr 10, 2024 ⎜ Company Industry Products

isoSolutions is pleased to announce the availability of Molybdenum Mo-100 (Radiochemical) with high enrichment and high purity from a cGMP facility.

Mo-100 is a stable isotope and it is widely used for research and studies of double beta-ray decay, in the nuclear medicine industry for imaging procedures after processing into Technetium Tc-99m in specialized cyclotrons.

For orders, please contact our Sales team or write to us at: and one of our team members will be happy to assist you.

isoSolutions is excited to announce our recent partnership with Agilent.

Lizeth ⎜Feb 9, 2024 ⎜ Company Industry Products


Q BioMed Signs Distribution Agreement with isoSolutions for the Sales of Strontium89 in Canada

Lizeth ⎜Aug 10, 2021 ⎜ Company Industry Products

Treatment with Strontium89 is available immediately in Canada via Named Patient Program

NEW YORK, Aug. 10, 2021 /PRNewswire/ — Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that it has recently entered into an exclusive distribution agreement with isoSolutions Marketing & Management Inc., a well-known distributor in Canada providing services and solutions to the nuclear medicine, radioisotope research, pharmaceutical, and medical device industries.  Under the terms of the agreement, isoSolutions has received exclusive rights to distribute Strontium89 in Canada.

Read More

isoSolutions supplier IRE is proud to announce a partnership with ASML

David T. Drummond ⎜Feb 1, 2018 ⎜ Products

IRE is proud to announce a partnership with ASML to further develop a new, non-fission production method for medical isotopes such as Mo-99/Tc-99m. This partnership has resulted in the start of the LightHouse Isotopes BV, an ambitious initiative for the development of a promising alternative production method for a sustainable long term supply of Mo-99.

Click here to see full post.


Automation of the Radiosynthesis of Six Different 18 F-labeled radiotracers on the AllinOne

David T. Drummond ⎜Nov 15, 2016 ⎜ Products

Fast implementation of positron emission tomography (PET) into clinical and preclinical studies highly demands automated synthesis for the preparation of PET radiopharmaceuticals in a safe and reproducible manner. The aim of this study was to develop automated synthesis methods for these six 18F-labeled radiopharmaceuticals produced on a routine basis at the University of Pennsylvania using (more…)


UPENN 2016 Automation of the Radiosynthesis of Six radiotracers

David T. Drummond ⎜Sep 24, 2016 ⎜ Products

[18F]Flubatine and
ln produced on a routine basis at UPENN with the Trasis AllinOne synthesizer.

By Ramona Delcea, Trasis Download pdf